1
|
Doersch KM, Campbell TD, Li A, Jain RK, Quarrier SO. Positive preoperative cultures but not bacterial species predict postoperative urine culture results after holmium laser enucleation of the prostate. Urol Ann 2024; 16:292-295. [PMID: 39600586 PMCID: PMC11587941 DOI: 10.4103/ua.ua_31_24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2024] [Accepted: 08/05/2024] [Indexed: 11/29/2024] Open
Abstract
Purpose The purpose of this study was to evaluate risk factors associated with positive urine cultures following holmium laser enucleation of the prostate (HoLEP). Materials and Methods The data from a prospectively maintained database were analyzed to evaluate urine culture results following HoLEP and determine the contribution of predefined variables (age, prostate size, Charlson comorbidity score, surgical time [surrogate for case difficulty], the presence of a catheter preoperatively, postoperative urinary retention, and preoperative positive culture) on urine culture positivity at 60 days postoperatively. Statistical analyses included logistic regression and ANOVA. Results The data from 136 subjects were included in the database and were evaluated at a median of 13.37 ± 6.72 months after their HoLEP. Postoperative positive cultures were noted in 23 subjects (16.91%). Preoperative positive cultures were found to predict positive postoperative urine cultures (odds ratio: 3.78, confidence interval: 1.18-12.78, P = 0.03). However, the preoperative and postoperative results were discordant in 9 of 14 subjects with both positive preoperative and postoperative cultures. Conclusions Positive preoperative cultures were predictive of positive postoperative cultures. However, the pre- and postoperative results were often discordant. Host factors increasing susceptibility to bacteriuria may explain these findings.
Collapse
Affiliation(s)
| | | | - Ashley Li
- University of Rochester Medical Center, Rochester, NY, USA
| | - Rajat K. Jain
- University of Rochester Medical Center, Rochester, NY, USA
| | | |
Collapse
|
2
|
Pramod N, Henry F, Ramanujan S, Jevnikar W, Bena J, Schwartz R, Jeffery J, Sorkhi S, Sauer R, McNall S, Freeman S, Wymer K, Mandeville J, Civellaro S, Humphreys M, Bhojani N, De S. High-Risk Patients Undergoing Holmium Laser Enucleation of the Prostate Have Fewer Infections with a Longer Course of Preoperative Antibiotics. J Endourol 2024; 38:598-604. [PMID: 38829325 DOI: 10.1089/end.2023.0503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2024] Open
Abstract
Introduction: There are minimal data to guide antibiotic management of patients undergoing holmium laser enucleation of the prostate (HoLEP) for benign prostatic hyperplasia. Specifically, management of high-risk patients who are catheter dependent or have positive preoperative urine cultures varies widely. We aimed to evaluate the effect of preoperative antibiotic duration on infectious complications in high-risk patients undergoing HoLEP. Methods: A multi-institutional retrospective review of patients undergoing HoLEP between 2018 and 2023 at five institutions was performed. Patients were defined as high risk if they were catheter-dependent (indwelling urethral catheter, self-catheterization, or suprapubic tube) or had a positive preoperative urine culture. These patients were categorized into long course (>3 days) or short course (≤3 days) of preoperative antibiotics. The primary outcome was 30-day infectious complications defined as a positive urine culture with symptoms. A t-test or Wilcoxon rank-sum test was used for continuous variables and Fisher's exact test was used for categorical variables. Logistic regression analysis was conducted to identify associations with infectious complications. Results: Our cohort included 407 patients, of which 146 (36%) and 261 (64%) were categorized as short course and long course of preoperative antibiotics, respectively. Median preoperative antibiotic duration was 1 day (interquartile range [IQR]: 0, 3 days) and 7 days (IQR: 5, 7 days) in the short and long cohorts, respectively. Thirty-day postoperative infectious complications occurred in 11 (7.6%) patients who received a short course of antibiotics and 5 (1.9%) patients who received a long course of antibiotics (odds ratio 0.24, 95% confidence interval 0.07-0.67; p = 0.009). Variables such as age, positive urine culture, and postoperative antibiotic duration were not significantly associated with postoperative infection after propensity score weighting. Conclusion: In high-risk patients undergoing HoLEP, infectious complications were significantly lower with a long course vs short course of antibiotics. Further prospective trials are needed to identify optimal preoperative antibiotic regimens.
Collapse
Affiliation(s)
- Nikhil Pramod
- Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Fabrice Henry
- Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Suruchi Ramanujan
- Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - William Jevnikar
- Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Jim Bena
- Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Ryan Schwartz
- Department of Surgery, University of Montreal, Montreal, Quebec, Canada
| | | | | | - Ruben Sauer
- Department of Urology, University of Illinois Chicago, Chicago, Illinois, USA
| | - Shannon McNall
- Lahey Hospital and Medical Center, Burlington, Massachusetts, USA
| | - Samantha Freeman
- Lahey Hospital and Medical Center, Burlington, Massachusetts, USA
| | | | | | - Simone Civellaro
- Department of Urology, University of Illinois Chicago, Chicago, Illinois, USA
| | | | - Naeem Bhojani
- Department of Surgery, University of Montreal, Montreal, Quebec, Canada
| | - Smita De
- Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio, USA
| |
Collapse
|
3
|
De S. EDITORIAL COMMENT. Urology 2022; 159:188-189. [PMID: 35027177 DOI: 10.1016/j.urology.2021.04.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2021] [Accepted: 04/30/2021] [Indexed: 11/26/2022]
Affiliation(s)
- Smita De
- Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH
| |
Collapse
|